Boxer Capital, LLC Tyra Biosciences, Inc. Transaction History
Boxer Capital, LLC
- $1.88 Billion
- Q3 2024
A detailed history of Boxer Capital, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 6,448,359 shares of TYRA stock, worth $90.7 Million. This represents 8.05% of its overall portfolio holdings.
Number of Shares
6,448,359
Previous 6,448,359
-0.0%
Holding current value
$90.7 Million
Previous $103 Million
47.03%
% of portfolio
8.05%
Previous 5.73%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$147 Million3.41% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$65.6 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$62 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$57.1 Million15.55% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$28 Million6.07% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $591M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...